Mon, Jan 26, 2015, 3:39 AM EST - U.S. Markets open in 5 hrs 51 mins

Recent

% | $
Quotes you view appear here for quick access.

Microsoft Corporation Message Board

calbucks09 5 posts  |  Last Activity: 14 hours ago Member since: Jan 26, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Pragmatic analysis

    by hparch Jan 24, 2015 10:01 AM
    calbucks09 calbucks09 14 hours ago Flag

    It was the analysts who pumped the stock throughout 2014 who set artificial investor expectations. that was the problem. then Anzalone got excited thinking they were a 'big story' and went all over tv... mistake there. then they blathered about blinded data too early and hyped more. another amateur hour mistake.

    so now investors really don't know how to evaluate the story. its simple, arwr will have to prove its story with actual cured patients. if it works it works. if it doesn't it goes back to $1

    nothing complex here folks. but this stock is not going to be running hard till data firmly shows the efficacy. 3mg, 4mg won't to it anymore.

  • calbucks09 calbucks09 Jan 17, 2015 7:17 PM Flag

    they are protecting their board seats and keeping their friends from being unseated on the board by a institutional investor interested in changing the strategy for monetizing the assets.

    its highly unlikely any hostile takeover is underway given the completely unproven nature of the assets and the competition ...

    there's a whole lot of shameless pumping going on here

  • Reply to

    Too much focus on single dose data 3&4mg/kg

    by bikerieder61 Dec 14, 2014 5:37 AM
    calbucks09 calbucks09 Dec 14, 2014 7:46 AM Flag

    while everyone here is excited about the prospects of Arc 520 based on the primate data, history is strewn with drugs that failed in human trials after positive primate studies. furthermore there are risks that competitors will have a faster or lower dose delivery option. so the idea that this is somehow a sure thing is totally ridiculous. if it were that easy roche would have kept the assets.

    I have a big chunk of cash in this and at higher prices, but this is absolutely a very risky investment. I hope people are not putting all their familys money into this. they've already had several failed drug development projects.

  • calbucks09 calbucks09 Dec 5, 2014 10:19 AM Flag

    there are 3 - 4 suits pending, if you read the 10k you can see the details. 2 require a lead plaintiff, which so far there is none. The others are not related to the securities laws, but to former subsidiaries that went bust.

  • Reply to

    Do you guys see the AH action,

    by ssheykhrez Nov 7, 2014 4:52 PM
    calbucks09 calbucks09 Nov 8, 2014 12:49 PM Flag

    Trades that were reported late. They likely were inst block sells during trading that were in dark pool and reported after trading.

MSFT
47.18+0.05(+0.11%)Jan 23 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.